Coordinated Action on HIV Clinical Research (CA44)

Presentation

This Coordinated Action promotes patient-centred scientific research with a focus on personalised medicine. Its founding principles combine:

the promotion of young researchers, particularly in low- and middle-income countries (LMICs),
close collaboration between Europe and LMICs
cross-cutting groups, in particular with CA41 ‘Host-virus interactions: basic and translational HIV research’ and CA53 ‘Sexually Transmitted Infections’,
a translational approach.

Activities and working groups

The Coordinated Action helps to determine research priorities. It provides scientific facilitation and networking for researchers, and encourages the emergence of promising projects using a bottom-up or top-down approach. These projects will be submitted to national and international calls for proposals, including those of ANRS MIE.

Workgroups

It is structured into two workgroups to cover the current research priorities of people living with HIV:

Antiretroviral strategies and co-morbidities
Immunotherapy (in partnership with the Coordinated Action on Host-Virus Interactions: basic and translational HIV research)

Next webinar: 6 July 2026

Virus-induced cancers in people living with HIV – HPV and HHV-8 in low- and middle-income countries

The AC44 “HIV Clinical Research” group of ANRS Maladies infectieuses émergentes is pleased to invite you to its upcoming webinar entitled: “Virus-induced cancers in people living with HIV – HPV and HHV-8 in low- and middle-income countries”, which will take place on 6 July 2026 from 5:00 p.m. to 7:00 p.m. (CET), via videoconference.

Agenda:

5:00–5:05 p.m. – Introduction: Serge Eholié, Maxime Hentzien, Alain Makinson

Part I: HPV-related cancers & people living with HIV (5:05–6:05 p.m.)

Chair: Charlotte Charpentier

5:05–5:15 p.m. – HIV and virus-induced cancers: epidemiology, priority diagnostic and care needs in LMICs – Gary Clifford
5:15–5:35 p.m. – Implementation and screening for cervical cancer among women living with HIV: gaps and needs – Speaker to be confirmed
5:35–5:45 p.m. – HPV vaccination: WHO single-dose strategy – what durability for people living with HIV? – Speaker to be confirmed
5:45–6:05 p.m. – Q&A – Chairs: Serge Eholié, Maxime Hentzien, Alain Makinson, Charlotte Charpentier

Part II: Kaposi’s disease in LMICs

Chair: Baptiste Abbar

6:05–6:25 p.m. – What are the needs in terms of diagnosis and care? – Speaker to be confirmed
6:25–6:35 p.m. – Kaposi’s disease in people with controlled HIV: pathophysiology, emergence and care challenges – Romain Palich
6:35–7:00 p.m. – Q&A – Chairs: Serge Eholié, Maxime Hentzien, Alain Makinson, Baptiste Abbar

Scientific committee: Alain Makinson, Maxime Hentzien, Serge Eholié, Charlotte Charpentier, Baptiste Abbar, Gary Clifford, Manon Ollivier, Romain Palich, Clinical Research Department of ANRS Maladies infectieuses émergentes

Registration

Contact:

Barbara Woomer b.woomer@bouisson-bertrand.fr

Previous Webinars

The ANRS MIE CA 44 ‘HIV Clinical Research’ is pleased to invite you to its first webinar entitled: “Research and innovation: what antiretroviral strategies in LMICs tomorrow?” which will take place on 27 May 2025 at 5pm by videoconference.

Agenda:

Moderators: Alain Makinson, Serge Eholié, Maxime Hentzien

5pm – 5.20pm: Presentation of the WHO report “DTG / TAF toxicity (including Body Weight Gain and cardiometabolic events)” – Didier Ekouevi and Serge Eholié
5.20pm – 5.40pm: Presentation of the WHO report “DRV/r vs ATV/r as a preferred PI option in 2nd line” – Marco Vitoria
5.40pm – 6pm: Resistance: state of play and impact on future strategies – Avelin F. Aghokeng
6pm – 7pm: Open round table “What research priorities on antiretroviral strategies in PRFIs?” – Didier Ekouevi, Charles Kouanfack (TBC), Françoise Renaud, Marco Vitoria, Roland Landman, Avelin F. Aghokeng, Yazdan Yazdanpanah